Endocrine disruption in human placenta: expression of the dioxin-inducible enzyme, CYP1A1, is correlated with that of thyroid hormone-regulated genesShow others and affiliations
2014 (English)In: Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, E-ISSN 1945-7197, Vol. 99, no 12, p. E2735-E2743Article in journal (Refereed) Published
Abstract [en]
CONTEXT: Thyroid hormone (TH) is essential for normal development; therefore, disruption of TH action by a number of industrial chemicals is critical to identify. Several chemicals including polychlorinated biphenyls are metabolized by the dioxin-inducible enzyme CYP1A1; some of their metabolites can interact with the TH receptor. In animals, this mechanism is reflected by a strong correlation between the expression of CYP1A1 mRNA and TH-regulated mRNAs. If this mechanism occurs in humans, we expect that CYP1A1 expression will be positively correlated with the expression of genes regulated by TH.
OBJECTIVE: The objective of the study was to test the hypothesis that CYP1A1 mRNA expression is correlated with TH-regulated mRNAs in human placenta.
METHODS: One hundred sixty-four placental samples from pregnancies with no thyroid disease were obtained from the GESTE study (Sherbrooke, Québec, Canada). Maternal and cord blood TH levels were measured at birth. The mRNA levels of CYP1A1 and placental TH receptor targets [placental lactogen (PL) and GH-V] were quantitated by quantitative PCR.
RESULTS: CYP1A1 mRNA abundance varied 5-fold across 132 placental samples that had detectable CYP1A1 mRNA. CYP1A1 mRNA was positively correlated with PL (r = 0.64; P < .0001) and GH-V (P < .0001, r = 0.62) mRNA. PL and GH-V mRNA were correlated with each other (r = 0.95; P < .0001), suggesting a common activator. The mRNAs not regulated by TH were not correlated with CYP1A1 expression.
CONCLUSIONS: CYP1A1 mRNA expression is strongly associated with the expression of TH-regulated target gene mRNAs in human placenta, consistent with the endocrine-disrupting action of metabolites produced by CYP1A1.
Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2014. Vol. 99, no 12, p. E2735-E2743
National Category
Endocrinology and Diabetes
Research subject
Enviromental Science
Identifiers
URN: urn:nbn:se:oru:diva-83750DOI: 10.1210/jc.2014-2629ISI: 000346743300086PubMedID: 25299844Scopus ID: 2-s2.0-84916613591OAI: oai:DiVA.org:oru-83750DiVA, id: diva2:1448118
Note
Funding Agency:
National Institutes of Health (NIH) - USA, Grant Number: RO1 ES010026
Fonds de Recherche du Quebec-Sante Grant, Grant Number: 12397
Canadian Institutes of Health Research (CIHR), Grant Number: MOP-84551
2020-06-262020-06-262021-03-04Bibliographically approved